Home > Income Statement > NATH BIOGENES (INDIA)

NATH BIOGENES (INDIA)
Operating Profit

    Back to Income Statement
NATH BIOGENES (INDIA) is part of below Screeners ↓
Top Undervalued Small Cap Stocks
COMMUNITY POLL
for NATH BIOGENES (INDIA)
Please provide your vote to see the results

NATH BIOGENES (INDIA) Last 5 Year Operating Profit History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2013
Operating Profit (Excl OI) ₹50 Cr₹50 Cr₹49 Cr₹37 Cr₹20 Cr

What is the latest Operating Profit of NATH BIOGENES (INDIA) ?

The latest Operating Profit ratio of NATH BIOGENES (INDIA) is ₹50 Cr based on Mar2025 Consolidated results.
Year Operating Profit
Mar2025₹50 Cr
Mar2024₹50 Cr
Mar2023₹49 Cr
Mar2022₹37 Cr
Mar2013₹20 Cr

How is Operating Profit of NATH BIOGENES (INDIA) Trending?

Years Operating Profit % Change
Mar2025 ₹50 Cr
0.02
Mar2024 ₹50 Cr
1.99
Mar2023 ₹49 Cr
31.59
Mar2022 ₹37 Cr
87.05
Mar2013 ₹20 Cr -

Compare Operating Profit of peers of NATH BIOGENES (INDIA)

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NATH BIOGENES (INDIA) ₹275.7 Cr 2.1% -5.7% -1% Stock Analytics
BOMBAY BURMAH TRADING CORPORATION ₹10,949.0 Cr -3.1% -12.1% -10.3% Stock Analytics
KAVERI SEED COMPANY ₹4,119.2 Cr 9.6% -8.6% -24.3% Stock Analytics
VENKYS (INDIA) ₹1,767.5 Cr -2.2% -13.3% -21.5% Stock Analytics
BOMBAY SUPER HYBRID SEEDS ₹885.6 Cr 0% -10% -38% Stock Analytics
INDO US BIOTECH ₹198.5 Cr -27.4% -25.7% -47.8% Stock Analytics


NATH BIOGENES (INDIA) Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
NATH BIOGENES (INDIA)

2.1%

-5.7%

-1%

SENSEX

-5%

-9.6%

3.1%


You may also like the below Video Courses